Exxonmobil Investment Management Inc. TX cut its position in shares of Colgate-Palmolive Co. (NYSE:CL) by 1.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 227,630 shares of the company’s stock after selling 3,528 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Colgate-Palmolive were worth $16,876,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Krilogy Financial LLC raised its stake in Colgate-Palmolive by 3.2% in the second quarter. Krilogy Financial LLC now owns 1,504 shares of the company’s stock valued at $110,000 after buying an additional 46 shares in the last quarter. Tompkins Financial Corp raised its stake in Colgate-Palmolive by 121.1% in the second quarter. Tompkins Financial Corp now owns 1,698 shares of the company’s stock valued at $124,000 after buying an additional 930 shares in the last quarter. Arcadia Investment Management Corp MI raised its stake in Colgate-Palmolive by 28.6% in the second quarter. Arcadia Investment Management Corp MI now owns 1,800 shares of the company’s stock valued at $132,000 after buying an additional 400 shares in the last quarter. FCM Investments TX bought a new stake in Colgate-Palmolive during the second quarter valued at about $132,000. Finally, Orrstown Financial Services Inc. raised its stake in Colgate-Palmolive by 26.7% in the second quarter. Orrstown Financial Services Inc. now owns 2,280 shares of the company’s stock valued at $167,000 after buying an additional 480 shares in the last quarter. Institutional investors and hedge funds own 73.12% of the company’s stock.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Shares of Colgate-Palmolive Co. (NYSE:CL) traded up 0.82% during trading on Friday, hitting $66.53. 1,302,337 shares of the company’s stock were exchanged. Colgate-Palmolive Co. has a 1-year low of $61.40 and a 1-year high of $75.38. The stock’s 50-day moving average price is $69.86 and its 200-day moving average price is $72.23. The stock has a market cap of $59.13 billion, a PE ratio of 43.51 and a beta of 0.73.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Thursday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.73. Colgate-Palmolive had a net margin of 8.96% and a return on equity of 6,924.14%. The firm earned $3.87 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same quarter last year, the business earned $0.80 EPS. The company’s revenue was down 3.3% compared to the same quarter last year. On average, equities analysts expect that Colgate-Palmolive Co. will post $2.82 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 15th. Shareholders of record on Monday, October 24th were issued a dividend of $0.39 per share. The ex-dividend date was Thursday, October 20th. This represents a $1.56 annualized dividend and a yield of 2.34%. Colgate-Palmolive’s payout ratio is 101.96%.

ILLEGAL ACTIVITY WARNING: “Colgate-Palmolive Co. (CL) Shares Sold by Exxonmobil Investment Management Inc. TX” was first reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/26/colgate-palmolive-co-cl-shares-sold-by-exxonmobil-investment-management-inc-tx.html.

Several research firms have issued reports on CL. B. Riley restated a “neutral” rating and issued a $71.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, August 3rd. JPMorgan Chase & Co. restated a “hold” rating and issued a $75.00 price target on shares of Colgate-Palmolive in a research report on Friday, July 29th. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price target on the stock in a research report on Monday, October 3rd. Exane BNP Paribas lowered shares of Colgate-Palmolive from an “outperform” rating to a “neutral” rating in a research report on Friday, July 29th. Finally, Citigroup Inc. raised their price target on shares of Colgate-Palmolive from $82.00 to $88.00 and gave the stock a “buy” rating in a research report on Friday, July 29th. Twelve equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and an average price target of $76.04.

In other Colgate-Palmolive news, insider Patricia Verduin sold 3,834 shares of the firm’s stock in a transaction that occurred on Monday, October 17th. The shares were sold at an average price of $72.39, for a total transaction of $277,543.26. Following the completion of the transaction, the insider now owns 55,013 shares in the company, valued at approximately $3,982,391.07. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 1.05% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Company’s segments include Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic segments, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.

5 Day Chart for NYSE:CL

Receive News & Stock Ratings for Colgate-Palmolive Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Co. and related stocks with our FREE daily email newsletter.